Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
Recruiting · NCT06734832 · Registry updated 2025-01-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Recruiting | Phase 3 | 2025-01-01 | NCT06734832 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sinovac Biotech Co., Ltd | 19 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Center for Disease Control and Prevention | Hefei | China | 3 |
| Fujian Provincial Center for Disease Control and Prevention | Fujian | China | 2 |
| Guangdong Provincial Center for Disease Control and Prevention | Guangdong | China | 1 |
| Hubei Provincial Center for Disease Control and Prevention | Hubei | China | 2 |